Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Cognitive Protection
NCT00455143Phase 4Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) and Post-operative cognitive dysfunction (POCD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Functional Recovery at 6 months. Started Sep 2006; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT00455143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455143.